| abstract |
The present invention relates to compounds of formula (I) and (IV), pharmaceutically acceptable salts, tautomers and stereoisomers thereof, which are inhibitors of histone deacetylase (HDAC). The compounds of the present invention are for use in the treatment of diseases ameliorated by inhibition of HDAC, such as cancer and abnormal hemoglobinosis such as β-thalassemia or sickle cell anemia. |